328 research outputs found
Influence of Six Herbicides Applied to Silage Corn on Fall Planted Rye and Radish Cover Crop Growth in South Dakota Soils
Spring preemergence herbicide applications are often used for burndown of existing weeds and residual control, eliminating weed presence during early season crop growth. There has been an increase in the interest in planting cover crops soon after cash crop removal, due to the potential soil and production benefits. However, soil herbicide residuals may result in poor cover crop growth. This study examined the growth of radish (Raphanus sativa) and rye (Secale cereal), species often used as cover crops, in soils that had been treated with residual herbicides about 100 d prior to cover crop planting. The herbicides were applied at recommended rates to silage corn in mid-May to early June at two sites, at a southern site near Beresford, SD (Egan-Trent Silty Clay Loam soil), and a northern site near Groton, SD (Beotia Silt Loam soil). Soil samples were collected in mid-September, and greenhouse studies were conducted to examine if herbicide activity was great enough to injure the cover crops. Plant height, and fresh weights of shoots and roots were compared to these parameters in plants grown in herbicide-free soil after six weeks of growth using a one-way paired t-test. Radish growth was unaffected by any herbicide. Several herbicides applied to the Groton soil reduced rye shoot weight, whereas in the Beresford soil, several herbicides reduced rye shoot height and root weight. Rye shoot weight was reduced by 59% in Warrant treated soil at Beresford, however, at Groton, three herbicides reduced shoot weight by about 25% (Python, Warrant, and Spirit). Rye shoot height was reduced by about 23% by two herbicides (Parallel, Warrant) in Groton soil and by about 16% by three herbicides (Glory, Python, Acuron) in the Beresford soil. Rye root weight was reduced by 35% or more by five herbicides (Parallel, Glory, Python, Warrant, and Acuron) in the Beresford soil, but only by Warrant (44%) in the Groton soil. These data indicate that herbicide residuals can be present in high enough concentrations after a short season crop to injure fall planted cover crops and that injury is herbicide, crop species, and soil specific. Further studies are needed to understand the influence of specific soil, herbicide, climatic conditions, and cover crop species where herbicide injury is possible. The results can be used by growers to select herbicide/cover crop species combinations that will be most successful for their farm
Hypertrophic Cardiomyopathy - Past, Present and Future
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a prevalence of 1 in 500 in the general population. Since the first pathological case series at post mortem in 1957, we have come a long way in its understanding, diagnosis and management. Here, we will describe the history of our understanding of HCM including the initial disease findings, diagnostic methods and treatment options. We will review the current guidelines for the diagnosis and management of HCM, current gaps in the evidence base and discuss the new and promising developments in this field
Osteochondral transplantation using autografts from the upper tibio-fibular joint for the treatment of knee cartilage lesions
Purpose Treatment of large cartilage lesions of the knee
in weight-bearing areas is still a controversy and challenging topic. Autologous osteochondral mosaicplasty has
proven to be a valid option for treatment but donor site
morbidity with most frequently used autografts remains a
source of concern. This study aims to assess clinical results
and safety profile of autologous osteochondral graft from
the upper tibio-fibular joint applied to reconstruct symptomatic osteochondral lesions of the knee.
Methods Thirty-one patients (22 men and 9 women) with
grade 4 cartilage lesions in the knee were operated by
mosaicplasty technique using autologous osteochondral
graft from the upper tibio-fibular joint, between 1998 and
2006. Clinical assessment included visual analog scale
(VAS) for pain and Lysholm score. All patients were
evaluated by MRI pre- and post-operatively regarding joint
congruency as good, fair (inferior to 1 mm incongruence),
and poor (incongruence higher than 1 mm registered in any
frame). Donor zone status was evaluated according to
specific protocol considering upper tibio-fibular joint
instability, pain, neurological complications, lateral collateral ligament insufficiency, or ankle complaints.
Results Mean age at surgery was 30.1 years (SD 12.2). In
respect to lesion sites, 22 were located in weight-bearing
area of medial femoral condyle, 7 in lateral femoral condyle, 1 in trochlea, and 1 in patella. Mean follow-up was
110.1 months (SD 23.2). Mean area of lesion was 3.3 cm
2
(SD 1.7), and a variable number of cylinders were used,
mean 2.5 (SD 1.3). Mean VAS score improved from 47.1
(SD 10.1) to 20.0 (SD 11.5); p = 0.00. Similarly, mean
Lysholm score increased from 45.7 (SD 4.5) to 85.3
(SD 7.0); p = 0.00. The level of patient satisfaction was
evaluated, and 28 patients declared to be satisfied/very
satisfied and would do surgery again, while 3 declared as
unsatisfied with the procedure and would not submit to
surgery again. These three patients had lower clinical scores
and kept complaints related to the original problem but
unrelated to donor zone. MRI score significantly improved
at 18–24 months comparing with pre-operative (p = 0.004).
No radiographic or clinical complications related to donor
zone with implication in activity were registered.
Conclusions This work corroborates that mosaicplasty
technique using autologous osteochondral graft from the
upper tibio-fibular joint is effective to treat osteochondral
defects in the knee joint. No relevant complications related
to donor zone were registered
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
BACKGROUND: There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in chronic obstructive pulmonary disease (COPD). OBJECTIVES: To determine whether or not regular (continuous, intermittent or pulsed) treatment of COPD patients with prophylactic antibiotics reduces exacerbations or affects quality of life. SEARCH METHODS: We searched the Cochrane Airways Group Trials Register and bibliographies of relevant studies. The latest literature search was performed on 27 July 2018. SELECTION CRITERIA: Randomised controlled trials (RCTs) that compared prophylactic antibiotics with placebo in patients with COPD. DATA COLLECTION AND ANALYSIS: We used the standard Cochrane methods. Two independent review authors selected studies for inclusion, extracted data, and assessed risk of bias. We resolved discrepancies by involving a third review author. MAIN RESULTS: We included 14 studies involving 3932 participants in this review. We identified two further studies meeting inclusion criteria but both were terminated early without providing results. All studies were published between 2001 and 2015. Nine studies were of continuous macrolide antibiotics, two studies were of intermittent antibiotic prophylaxis (three times per week) and two were of pulsed antibiotic regimens (e.g. five days every eight weeks). The final study included one continuous, one intermittent and one pulsed arm. The antibiotics investigated were azithromycin, erythromycin, clarithromycin, doxycyline, roxithromycin and moxifloxacin. The study duration varied from three months to 36 months and all used intention-to-treat analysis. Most of the pooled results were of moderate quality. The risk of bias of the included studies was generally low.The studies recruited participants with a mean age between 65 and 72 years and mostly at least moderate-severity COPD. Five studies only included participants with frequent exacerbations and two studies recruited participants requiring systemic steroids or antibiotics or both, or who were at the end stage of their disease and required oxygen. One study recruited participants with pulmonary hypertension secondary to COPD and a further study was specifically designed to asses whether eradication of Chlamydia pneumoniae reduced exacerbation rates.The co-primary outcomes for this review were the number of exacerbations and quality of life.With use of prophylactic antibiotics, the number of participants experiencing one or more exacerbations was reduced (odds ratio (OR) 0.57, 95% CI 0.42 to 0.78; participants = 2716; studies = 8; moderate-quality evidence). This represented a reduction from 61% of participants in the control group compared to 47% in the treatment group (95% CI 39% to 55%). The number needed to treat for an additional beneficial outcome with prophylactic antibiotics given for three to 12 months to prevent one person from experiencing an exacerbation (NNTB) was 8 (95% CI 5 to 17). The test for subgroup difference suggested that continuous and intermittent antibiotics may be more effective than pulsed antibiotics (P = 0.02, I² = 73.3%).The frequency of exacerbations per patient per year was also reduced with prophylactic antibiotic treatment (rate ratio 0.67; 95% CI 0.54 to 0.83; participants = 1384; studies = 5; moderate-quality evidence). Although we were unable to pool the result, six of the seven studies reporting time to first exacerbation identified an increase (i.e. benefit) with antibiotics, which was reported as statistically significant in four studies.There was a statistically significant improvement in quality of life as measured by the St George's Respiratory Questionnaire (SGRQ) with prophylactic antibiotic treatment, but this was smaller than the four unit improvement that is regarded as being clinically significant (mean difference (MD) -1.94, 95% CI -3.13 to -0.75; participants = 2237; studies = 7, high-quality evidence).Prophylactic antibiotics showed no significant effect on the secondary outcomes of frequency of hospital admissions, change in forced expiratory volume in one second (FEV1), serious adverse events or all-cause mortality (moderate-quality evidence). There was some evidence of benefit in exercise tolerance, but this was driven by a single study of lower methodological quality.The adverse events that were recorded varied among the studies depending on the antibiotics used. Azithromycin was associated with significant hearing loss in the treatment group, which was in many cases reversible or partially reversible. The moxifloxacin pulsed study reported a significantly higher number of adverse events in the treatment arm due to the marked increase in gastrointestinal adverse events (P < 0.001). Some adverse events that led to drug discontinuation, such as development of long QTc or tinnitus, were not significantly more frequent in the treatment group than the placebo group but pose important considerations in clinical practice.The development of antibiotic resistance in the community is of major concern. Six studies reported on this, but we were unable to combine results. One study found newly colonised participants to have higher rates of antibiotic resistance. Participants colonised with moxifloxacin-sensitive pseudomonas at initiation of therapy rapidly became resistant with the quinolone treatment. A further study with three active treatment arms found an increase in the degree of antibiotic resistance of isolates in all three arms after 13 weeks treatment. AUTHORS' CONCLUSIONS: Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbations in COPD patients. All studies of continuous and intermittent antibiotics used macrolides, hence the noted benefit applies only to the use of macrolide antibiotics prescribed at least three times per week. The impact of pulsed antibiotics remains uncertain and requires further research.The studies in this review included mostly participants who were frequent exacerbators with at least moderate-severity COPD. There were also older individuals with a mean age over 65 years. The results of these studies apply only to the group of participants who were studied in these studies and may not be generalisable to other groups.Because of concerns about antibiotic resistance and specific adverse effects, consideration of prophylactic antibiotic use should be mindful of the balance between benefits to individual patients and the potential harms to society created by antibiotic overuse. Monitoring of significant side effects including hearing loss, tinnitus, and long QTc in the community in this elderly patient group may require extra health resources
Differences in joint morphology between the knee and ankle affect the repair of osteochondral defects in a rabbit model
MACI - a new era?
Full thickness articular cartilage defects have limited regenerative potential and are a significant source of pain and loss of knee function. Numerous treatment options exist, each with their own advantages and drawbacks. The goal of this review is to provide an overview of the problem of cartilage injury, a brief description of current treatment options and outcomes, and a discussion of the current principles and technique of Matrix-induced Autologous Chondrocyte Implantation (MACI). While early results of MACI have been promising, there is currently insufficient comparative and long-term outcome data to demonstrate superiority of this technique over other methods for cartilage repair
Effect of dynamic compressive loading and its combination with a growth factor on the chondrocytic phenotype of 3-dimensional scaffold-embedded chondrocytes
Background and purpose Three-dimensionally (3D-) embedded chondrocytes have been suggested to maintain the chondrocytic phenotype. Furthermore, mechanical stress and growth factors have been found to be capable of enhancing cell proliferation and ECM synthesis. We investigated the effect of mechanical loading and growth factors on reactivation of the 3D-embedded chondrocytes
The subchondral bone in articular cartilage repair: current problems in the surgical management
As the understanding of interactions between articular cartilage and subchondral bone continues to evolve, increased attention is being directed at treatment options for the entire osteochondral unit, rather than focusing on the articular surface only. It is becoming apparent that without support from an intact subchondral bed, any treatment of the surface chondral lesion is likely to fail. This article reviews issues affecting the entire osteochondral unit, such as subchondral changes after marrow-stimulation techniques and meniscectomy or large osteochondral defects created by prosthetic resurfacing techniques. Also discussed are surgical techniques designed to address these issues, including the use of osteochondral allografts, autologous bone grafting, next generation cell-based implants, as well as strategies after failed subchondral repair and problems specific to the ankle joint. Lastly, since this area remains in constant evolution, the requirements for prospective studies needed to evaluate these emerging technologies will be reviewed
- …